Share

Nucleus Software Exports Limited Stocks

792.95Last Updated 13.04.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 223.57M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
792.95
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nucleus Software Exports Limited provides mission critical lending and transaction banking products to the financial services industry in India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally. Its products include FinnOne Neo, a lending solution designed to support retail, corporate, and Islamic sectors for banks and other financial service companies; FinnOne Neo customer acquisition system, a loan origination software; FinnOne Neo loan management system; FinnOne Neo collections, a customer centric, web based, and workflow driven solution; and FinnOne Neo enterprise content management provides image based processing capabilities in loan acquisitions and various lifecycle events. The company also offers FinnOn Neo mobility suite; FinnOne Neo internet channel suite; FinnOne Neo CAS supports finance against securities; FinnOne Neo collateral management system; and FinnOne Neo payout management system. In addition, it offers FinnAxia, an integrated global transaction banking solution comprising global receivables, global payments, global liquidity management, financial supply chain management, virtual account management, digital compass, e-Trade Finance, and business internet banking, as well as advisory services; FarEdge, a comprehensive analytics solution enabling banks to extract, analyze, interpret and transform their business data in order to detect fraudulent and dual transactions early; FinnOne Neo digital portal for loan self-sourcing; and digital channels that enable banks and financial services companies to provide digital lending on mobile and web portals. Further, the company provides testing and consulting; application development and management, digital transformation, data management and analytics, mobile and web application, and verification and validation; and managed infrastructure services. Nucleus Software Exports Limited was founded in 1986 and is headquartered in Noida, India.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of NUCLEUS.NS is 1350 and suggests 70% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks